The Interferon-Gamma Paradox in Cancer

• Published in: Journal of interferon & cytokine research Vol. 39; no. 1; p. 30
• Main Author: Zaidi, M Raza
• Format: Journal Article
• Language: English
• Published: United States 01-01-2019
• Subjects: Animals; Humans; Interferon-gamma - immunology; Neoplasms - immunology; Signal Transduction - immunology; cytokine signaling; immunoevasion; cancer; immunosurveillance; interferon-gamma; immunoediting
• ISSN: 1557-7465
• DOI: 10.1089/jir.2018.0087

Interferon-gamma (IFNG) has long been implicated as a central orchestrator of antitumor immune responses in the elimination stage of the immunoediting paradigm. However, mounting evidence suggests that IFNG may also have important and significant protumor roles to play in the equilibrium and escape phases through its regulatory effects on immunoevasive functions that promote tumorigenesis. These seemingly contradictory effects of IFNG undoubtedly play profound roles in not only the activation of inflammatory response to cancer but also in the determination of its outcome. In the face of the recent explosion of anticancer immunotherapeutic strategies in the clinic, it is critical that a complete understanding is achieved of the underpinnings of the mechanisms that determine the two faces of IFNG signaling in cancer. Here, the current state of this dichotomy is reviewed.